Artelo Biosciences (ARTL) had the highest return since November 30, 2017 and in June 2019 by a US stock, returning 10,136.3%.
| ASSET | % RETURN |
|---|---|
Artelo Biosciences (ARTL) | 10,136.29% |
Castellum (CTM) | 833.33% |
MMTEC (MTC) | 240% |
Meridian (MRDN) | 136% |
Hf Foods (HFFG) | 132.07% |
AIOS Tech (AIOS) | 112.5% |
American Bitcoin (ABTC) | 111.56% |
Maase (MAAS) | 111.13% |
CEL-SCI (CVM) | 110.03% |
Workhorse (WKHS) | 104.17% |
OLB (OLB) | 100% |
Vuzix Corp Cmn Stk (VUZI) | 96.63% |
Enlivex Therapeutics (ENLV) | 93.52% |
DeFi Technologies (DEFT) | 93.42% |
Revolve Group LLC (RVLV) | 91.67% |
Rekor Systems (REKR) | 88.89% |
Foresight Autonomous Holdings Ltd ADR (FRSX) | 87.23% |
DiaMedica Therapeutics (DMAC) | 86.54% |
Rafael (RFL) | 81.51% |
Abits (ABTS) | 80% |
Envela (ELA) | 73.33% |
Arena (AREN) | 71.05% |
Quince Therapeutics (QNCX) | 69.9% |
Lifeway Foods (LWAY) | 69.3% |
DRDGOLD Limited ADR (DRD) | 64.86% |